PRGO
36
3
HBI
58
2
KR
52
2
LRCX
61
2
JPM
64
2
OI
30
5
K
56
3
ADBE
55
4
STX
35
-2
MET
60
2
XRAY
34
3
AAP
32
2
LNC
32
3
WYNN
36
2
DG
14
2
YUM
45
2
MSI
55
-2
BK
65
2
NRG
37
-2
ADT
32
4
PRGO
36
3
HBI
58
2
KR
52
2
LRCX
61
2
JPM
64
2
OI
30
5
K
56
3
ADBE
55
4
STX
35
-2
MET
60
2
XRAY
34
3
AAP
32
2
LNC
32
3
WYNN
36
2
DG
14
2
YUM
45
2
MSI
55
-2
BK
65
2
NRG
37
-2
ADT
32
4
Financhill
Back

Armata Pharmaceuticals 10K Form

Sell
48

ARMP
Armata Pharmaceuticals

Last Price:
$2.07
Seasonality Move:
10.32%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ARMP News And Ratings

See the #1 stock for the next 7 days that we like better than ARMP

ARMP Financial Statistics

Sales & Book Value

Annual Sales: $820K
Cash Flow: $-9.2M
Price / Cash Flow: 0
Annual Sales: $-1.41
Price / Book: 0

Profitability

EPS (TTM): -1.64000
Net Income (TTM): $-41.4M
Gross Margin: $410K
Return on Equity: 0%
Return on Assets: 0%

Armata Pharmaceuticals Earnings Forecast

Key Armata Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 19 years for ARMP is 100.24%.
  • The Selling, General & Administrative Expenses for ARMP have been equal to 971.46% of Gross Profit Margin.
  • The Interest Expense is -3.80% of Operating Income.
  • Per Share Earnings over the last 28 years have been positive in 11 years.

Armata Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYAM
Industry: Biotechnology
Sector: Health Care
Current Symbol: ARMP
CUSIP: 04216R
Website: armatapharma.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ARMP Technical Analysis vs Fundamental Analysis

Sell
48
Armata Pharmaceuticals (ARMP) is a Sell

Is Armata Pharmaceuticals a Buy or a Sell?